Johns Hopkins IRBipilimumabnivolumabFibrolamellar carcinoma (FLC)DNAJ-PKAcT Cell Receptor (TCR)-Based cellular therapy
…rial Registration NCT04248569Ethics Approval J19140/IRB00222681 Johns Hopkins IRB Participants gave informed written consent before taking part i…